Notice Regarding Completion of Cancellation of Treasury Stock
Filed with TSE · · 1 page · English
Summary by 6ix AI
Sysmex Corporation has announced the completion of the cancellation of treasury stock as resolved by its Board of Directors earlier this year.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from Sysmex
- Announcement Regarding Revision of Financial Forecast for FY26 1H and FY26 full year
- Notice Regarding the Status and Completion of Acquisition of Treasury Stock and Cancellation of Treasury Stock
- High diagnostic performance of the random-access hiscl ptau-217, Aβ42 and Aβ40 plasma assays in detecting amyloid pathology across clinical stages
- Notice Concerning the Status of Acquisition of Treasury Stock
- Sysmex: Genetic Testing Using Sysmex’s Assay Kit Receives Insurance Coverage as the First of Its Kind in Japan for Assessing the Risk of Adverse Reactions to Anti-Amyloid β Antibody Drugs
Later from Sysmex
- Announcement Regarding Impairment Loss(Consolidated Financial Results),and Revision of Financial Forecast for the Six Months Ending September 30,2026
- Announcement Regarding Revision of Full-Year Financial Forecast for the Fiscal Year Ending March 31, 2027
- Summary of Consolidated Financial Results [IFRS] for the First Six Months of the Fiscal Year Ending March 31, 2027
- Sysmex: Posted Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2027
Follow Sysmex into a list and get an email when it puts out news.
Follow Sysmex